XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative effect adjustment
Beginning balance (in shares) at Jun. 30, 2019     144,433          
Beginning balance at Jun. 30, 2019 $ 4,673,865 $ 3,018 $ 144 $ 6,409,405 $ (11,602,573) $ (64,030) $ 9,930,919 $ 3,018
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     183          
Issuance of common stock 4,501     4,501        
Purchase of treasury stock (in shares)     (3,639)          
Purchase of treasury stock (1,083,459)   $ (3)   (1,083,456)      
Reissuance of treasury stock (in shares)     296          
Reissuance of treasury stock 38,447     25,710 12,737      
Equity-based compensation expense 88,630     88,630        
Effect of conversion of convertible notes (in shares)     1,189          
Effect of conversion of convertible notes (10,559)   $ 1 (10,560)        
Reclassification from temporary to permanent equity 11,135     11,135        
Net income 980,299           980,299  
Other comprehensive income (loss) 3,783         3,783    
Cash dividends declared (330,231)           (330,231)  
Ending balance (in shares) at Dec. 29, 2019     142,462          
Ending balance at Dec. 29, 2019 4,379,429   $ 142 6,528,821 (12,673,292) (60,247) 10,584,005  
Beginning balance (in shares) at Sep. 29, 2019     144,871          
Beginning balance at Sep. 29, 2019 4,936,393   $ 145 6,456,492 (11,680,689) (72,560) 10,233,005  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     72          
Issuance of common stock 632     632        
Purchase of treasury stock (in shares)     (3,242)          
Purchase of treasury stock (1,005,343)   $ (3)   (1,005,340)      
Reissuance of treasury stock (in shares)     296          
Reissuance of treasury stock 38,447     25,710 12,737      
Equity-based compensation expense 45,725     45,725        
Effect of conversion of convertible notes (in shares)     465          
Effect of conversion of convertible notes (3,987)     (3,987)        
Reclassification from temporary to permanent equity 4,249     4,249        
Net income 514,510           514,510  
Other comprehensive income (loss) 12,313         12,313    
Cash dividends declared (163,510)           (163,510)  
Ending balance (in shares) at Dec. 29, 2019     142,462          
Ending balance at Dec. 29, 2019 4,379,429   $ 142 6,528,821 (12,673,292) (60,247) 10,584,005  
Beginning balance (in shares) at Jun. 28, 2020     145,331          
Beginning balance at Jun. 28, 2020 5,172,494 [1] 1,157 [2] $ 145 6,695,858 (12,949,889) (94,211) 11,520,591 1,157 [2]
Ending balance (in shares) at Sep. 27, 2020     144,593          
Ending balance at Sep. 27, 2020 5,419,185   $ 145 6,761,545 (13,416,986) (82,672) 12,157,153  
Beginning balance (in shares) at Jun. 28, 2020     145,331          
Beginning balance at Jun. 28, 2020 5,172,494 [1] $ 1,157 [2] $ 145 6,695,858 (12,949,889) (94,211) 11,520,591 $ 1,157 [2]
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     205          
Issuance of common stock 13,646     13,646        
Purchase of treasury stock (in shares)     (3,156)          
Purchase of treasury stock (1,194,842)   $ (3)   (1,194,839)      
Reissuance of treasury stock (in shares)     207          
Reissuance of treasury stock 41,434     32,261 9,173      
Equity-based compensation expense 108,097     108,097        
Effect of conversion of convertible notes (in shares)     618          
Effect of conversion of convertible notes (660)   $ 1 (661)        
Reclassification from temporary to permanent equity 5,480     5,480        
Net income 1,692,680           1,692,680  
Other comprehensive income (loss) 38,085         38,085    
Cash dividends declared (374,538)           (374,538)  
Ending balance (in shares) at Dec. 27, 2020     143,205          
Ending balance at Dec. 27, 2020 5,503,033   $ 143 6,854,681 (14,135,555) (56,126) 12,839,890  
Beginning balance (in shares) at Sep. 27, 2020     144,593          
Beginning balance at Sep. 27, 2020 5,419,185   $ 145 6,761,545 (13,416,986) (82,672) 12,157,153  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     100          
Issuance of common stock 8,108     8,108        
Purchase of treasury stock (in shares)     (1,796)          
Purchase of treasury stock (727,744)   $ (2)   (727,742)      
Reissuance of treasury stock (in shares)     207          
Reissuance of treasury stock 41,434     32,261 9,173      
Equity-based compensation expense 52,109     52,109        
Effect of conversion of convertible notes (in shares)     101          
Effect of conversion of convertible notes (134)     (134)        
Reclassification from temporary to permanent equity 792     792        
Net income 869,229           869,229  
Other comprehensive income (loss) 26,546         26,546    
Cash dividends declared (186,492)           (186,492)  
Ending balance (in shares) at Dec. 27, 2020     143,205          
Ending balance at Dec. 27, 2020 $ 5,503,033   $ 143 $ 6,854,681 $ (14,135,555) $ (56,126) $ 12,839,890  
[1] Derived from audited financial statements
[2] (1) Refer to Note 2 - Recent Accounting Pronouncements for more information regarding this FASB Accounting Standard Updates.